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Abstract Palytoxin (PTX) induces a cation channel through
interaction with Na+,K+-ATPase. It is unclear how this action
relates to the enzyme catalytic activity. We examined whether
the action of PTX depends on the catalytic domain speci¢c
for Na+,K+-ATPase. Wild-type Na+,K+-ATPase K-subunit
(NNN) or its chimera (NCN), in which the catalytic domain
was replaced with that of sarcoplasmic/endoplasmic reticulum
Ca2+-ATPase, was co-expressed with L-subunit in the yeast
Saccharomyces cerevisiae. PTX (0.1^100 nM) increased K+
e¥ux in NNN- or NCN-transfected cells to a similar degree
but not in non-transfected cells. When ouabain-resistant NNN
and NCN were expressed, PTX also increased K+ e¥ux. Oua-
bain inhibited the e¡ect of PTX in NNN or NCN cells but not
in ouabain-resistant cells. These data suggest that the channel-
forming action of PTX does not depend on the catalytic domain
species.
1 2003 Published by Elsevier Science B.V. on behalf of the
Federation of European Biochemical Societies.
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1. Introduction
Palytoxin (PTX), isolated from Palythoa spp., is the most
potent marine toxin known. We have reported that PTX in-
duces a cation channel, which is permeable to monovalent
cations, in cardiac ventricular or vascular smooth muscle cells
[1^3]. Its lethal action is ascribed to an increase in cytosolic
Naþ concentration and the subsequent increase in cytosolic
Ca2þ [4]. Cardiac glycosides such as ouabain antagonize the
action of PTX and many reports suggest that the site of action
of PTX is the Naþ,Kþ-ATPase (for review, [5]). This hypoth-
esis was proved by the work of Scheiner-Bobis’s group, in
which they showed that PTX increased Kþ permeability in
yeast cells transfected with the Naþ,Kþ-ATPase but not in
non-transfected cells [6]. It is supposed that the Naþ,Kþ-ATP-
ase includes a channel, which permits passage of Naþ and Kþ
[7,8]. Therefore, the PTX-sensitive channel is thought to in-
herently exist in the enzyme and to be responsible for trans-
port of Naþ and Kþ. However, it has not been determined
where the PTX-sensitive channel is located in the enzyme and
whether the action of PTX to open the channel depends on
the catalytic activity.
In order to determine whether the PTX-sensitive channel
activity depends on the catalytic domain species of the en-
zyme, we co-expressed a chimeric K-subunit composed of
the Naþ,Kþ-ATPase and the catalytic domain of the sarco-
plasmic/endoplasmic Ca2þ-ATPase (SERCA) with the L-sub-
unit in the yeast Saccharomyces cerevisiae, which does not
contain endogenous Naþ,Kþ-ATPase [9], and observed the
e¡ect of PTX to increase Kþ e¥ux from the cells as an index
of channel-forming action.
2. Materials and methods
2.1. cDNA construction
We wanted to construct a chimeric ATPase (NCN), in which the
large cytoplasmic loop between the two putative membrane-spanning
regions M4 and M5 was exchanged between the chicken Naþ,Kþ-
ATPase K1-subunit (NNN) [10] and the chicken SERCA1 (CCC)
[11]. This was done by recombination between the encoding cDNAs.
The 3P- and 5P-ends of the exchanged fragments were generated by the
restriction enzymes for the unique endogenous EcoNI site [12] and the
unique introduced KpnI site [13], respectively. The endogenous EcoNI
site corresponds to Lys724 of NNN or Lys712 of CCC. The unique
KpnI site at the position encoding Gly377 of NNN or Gly354 of CCC
was created by oligonucleotide-directed mutagenesis without amino
acid mutation.
For the construction of ouabain-resistant NNN (ORNNN) or
NCN (ORNCN), the cDNA sequences corresponding to Thr116 and
Asn127 in NNN or NCN were mutated to Arg and Asp, respectively,
using the QuickChange Site-Directed Mutagenesis Kit (Stratagene, La
Jolla, CA, USA). Mutation at these sites renders the enzyme resistant
to ouabain [14,15].
2.2. Expression of cDNAs in yeast cells
Synthetic complete and drop-out media were prepared in a manner
similar to that described elsewhere [16]. The cDNAs encoding NNN,
NCN, ORNNN and ORNCN were cloned into a yeast expression
vector, pYES2 (Invitrogen Japan, Tokyo, Japan) and then introduced
into yeast S. cerevisiae strain BJ3505 cells (Mata pep4: :HIS3 prb1-
D1.6R HIS3 lys2-208 trp1-D101 ura3-52 gal2 can) [17] together with
the chicken Naþ,Kþ-ATPase L-subunit cDNA cloned into a NMV4
expression vector (L-NMV4, TRP1, CEN4) [18] using the lithium
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acetate method. Transfected cells were grown for 2^4 days on a syn-
thetic selection plate lacking uracil and tryptophan at 30‡C until col-
ony formation. Then, the colony was inoculated into a test tube con-
taining liquid selective medium and incubated for 24 h.
The K- and L-subunits were co-expressed under control of the
GAL1 promoter in the selective medium containing 2% galactose.
Four to eight hours later, the cells were collected, centrifuged at
3000Ug for 5 min at 4‡C and subjected to experimentation.
2.3. K+ e¥ux from transfected yeast cells
The cells were suspended at a concentration of 1U107 cells/ml in
NHBC bu¡er (in mM: 200 NaCl, 10 HEPES, 0.5 borate, 1 CaCl2, pH
7.5), rinsed twice with NHBC bu¡er to remove extracellular Kþ, then
resuspended in the bu¡er.
PTX at each concentration was added to the cell suspension in a
test tube, incubated for an appropriate time and then centrifuged at
12 000Ug for 1 min at 4‡C. Potassium in the supernatant was mea-
sured as Kþ e¥ux from the cells by £ame photometry. To measure
potassium remaining in the cells, lysis bu¡er (0.02% sodium dodecyl
sulfate, 200 mM NaCl, 10 mM HEPES, 0.5 mM borate, 1 mM CaCl2,
pH 7.5) was added to the pellet. The cells were destroyed by boiling
for 10 min at 95‡C and centrifuged at 12 000Ug for 1 min at 4‡C.
Potassium concentration in the supernatant was measured to estimate
residual potassium in the cells. The intracellular volume of yeast cells
was calculated as described previously [19].
3. Results
3.1. PTX-induced K+ e¥ux in cells transfected with wild-type
Na+,K+-ATPase and chimeric ATPase
First, we measured the PTX-induced Kþ e¥ux from yeast
cells transfected with NNN or NCN. PTX (0.1^100 nM) dose-
dependently increased Kþ e¥ux in NNN- or NCN-trans-
fected cells, whereas PTX at the highest concentration (100
nM) did not stimulate Kþ e¥ux in non-transfected cells (Fig.
1). The amount of Kþ e¥uxed from the cells over 2 h was
similar between NNN- and NCN-transfected cells at each
PTX concentration and the concentration^response curves
overlapped. PTX (100 nM)-induced Kþ e¥ux 2 h after appli-
cation was 57.4S 7.3% (n=6) in NNN cells and 65.4S 11.1%
(n=6) in NCN cells of the total cellular Kþ. However, the
time-course of Kþ e¥ux induced by 100 nM PTX in NCN
cells was slow compared to that in NNN cells (Fig. 2). When
borate was absent in the external medium, the amount of Kþ
that e¥uxed from the cells decreased to about half of that in
the presence of 1 mM borate (31.1 S 1.1% vs. 64.3 S 0.7% in
the absence or presence of borate, respectively (n=6), 2 h
after application of PTX in NNN cells), consistent with the
data that borate promoted the action of PTX [20,21].
3.2. E¡ects of ATPase inhibitors
Ouabain (10^100 WM) inhibited the PTX-induced Kþ e¥ux.
The inhibition by ouabain was slightly greater in NNN cells
than in NCN cells (Fig. 3). On the other hand, thapsigargin
(1 WM), a SERCA inhibitor, did not a¡ect the e¥ux in either
NNN or NCN cells (data not shown). Likewise, amiloride (30
WM), which inhibits Naþ-Hþ exchange, Naþ-Ca2þ exchange
and epithelial Naþ channels, had no e¡ect on the PTX-in-
duced Kþ e¥ux (data not shown).
When sodium orthovanadate (50^200 WM), which inhibits a
P-type ATPase by competing with ATP at the catalytic site,
was applied 2 h before the addition of PTX (100 nM), the
action of PTX to cause Kþ e¥ux was inhibited to a similar
degree in NNN- and NCN-transfected cells (Fig. 4). In other
experiments, sodium azide (0.5 or 1 mM), which inhibits ATP
production, was applied to cells 2 h before PTX. Sodium
azide also depressed the action of 100 nM PTX (Fig. 4).
Fig. 1. Concentration-dependent e¡ect of PTX on Kþ e¥ux from
yeast cells transfected with NNN or NCN. Kþ that £owed out
from NNN- (circles), NCN- (squares) or non-transfected (triangles)
cells over 2 h after application of PTX is expressed as percentage of
total cellular K. Each point represents meanSS.E.M. of six deter-
minations.
 
Fig. 2. Time-course of PTX-induced Kþ e¥ux from yeast cells
transfected with NNN or NCN. PTX (100 nM) was applied at time
0 to NNN- (open circles) or NCN- (open squares) transfected cells.
Kþ e¥ux is expressed as percentage of total cellular Kþ. Closed
circles and closed squares are control Kþ e¥ux in the absence of
PTX. Each point represents meanSS.E.M. of six determinations.
Fig. 3. E¡ect of ouabain on the PTX-induced Kþ e¥ux in NNN-
or NCN-transfected cells (left panel) and in ORNNN- or ORNCN-
transfected cells (right panel). Cells were pretreated with ouabain 30
min prior to PTX. Kþ e¥ux is expressed as percentage of total cel-
lular Kþ. Each point represents meanSS.E.M. of six determina-
tions. *P6 0.05, **P6 0.01 (vs. in the absence of ouabain, Dun-
nett’s post-hoc test following ANOVA).
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3.3. Action of PTX in ouabain-resistant cells
Next, we tested the e¡ect of PTX on ORNNN- or
ORNCN-transfected cells. PTX (100 nM) increased Kþ e¥ux
from these cells (Fig. 5). The maximum e¡ect was similar
between ORNNN or ORNCN cells. Ouabain at 100 WM
did not a¡ect the PTX-induced Kþ e¥ux (Fig. 3).
Sodium orthovanadate (50^200 WM) inhibited the PTX-in-
duced Kþ e¥ux in ORNNN- or ORNCN-transfected cells,
although the inhibition was smaller than the case in NNN
or NCN cells. Two hours pretreatment with sodium azide
(0.5 or 1 mM) also inhibited the Kþ e¥ux in these cells. In
this case, too, the inhibitory e¡ect of sodium azide was less
compared to the e¡ect on ouabain-sensitive cells.
4. Discussion
Habermann’s group ¢rst speculated that the site of action
of PTX was within the Naþ,Kþ-ATPase or in its vicinity
[21,22]. Later studies demonstrated that PTX interacts with
the Naþ,Kþ-ATPase since PTX exerted an e¡ect when the
Naþ,Kþ-ATPase was expressed in yeast cells [6], which do
not have the endogenous enzyme, or when the Naþ,Kþ-ATP-
ase protein was incorporated into a liposome [23] or a planar
lipid bilayer [24,25]. The present study employed yeast expres-
sion system as used by Scheiner-Bobis’s group [6] and our
data were in agreement with the above ¢ndings since PTX
increased Kþ e¥ux in yeast cells that were transfected with
cDNA encoding the Naþ,Kþ-ATPase but not in non-trans-
fected cells.
Naþ,Kþ-ATPase and SERCA are P-type ATPases, which
undergo a cyclic change of phosphorylated and dephosphor-
ylated conformations and have about 30% identity in amino
acid sequences. The domain responsible for ATP hydrolysis is
a central part of the ATPase located in the cytoplasmic loop
between the fourth and ¢fth membrane-spanning regions. In
the chimera NCN, the catalytic domain of the Naþ,Kþ-ATP-
ase K-subunit was replaced with that of SERCA. An impor-
tant ¢nding in this study is that PTX induced channel activity
not only in cells expressing NNN but also in cells expressing
NCN. Although the development of Kþ e¥ux after treatment
with PTX in NCN cells was slow compared to that in NNN
cells, the maximum e¡ect was similar between two cell types
and the concentration^response curve for the NCN cells over-
lapped that for the wild-type expressing cells. This strongly
suggests that the induction of a channel by PTX does not
depend on the catalytic domain species. The PTX-sensitive
channel and the PTX binding site were clearly preserved after
the catalytic domain was replaced with that of SERCA. The
overlapping of concentration^e¡ect curves for NNN and
NCN implies that replacement of the catalytic domain did
not a¡ect the a⁄nity of PTX to the K-subunit. Nevertheless,
the possibility remains that a conformational change after
insertion of the domain from SERCA may make the induc-
tion of a channel by PTX less easy because the development
of PTX-induced Kþ e¥ux was slowed in NCN cells.
Scheiner-Bobis and Schneider [26] reported that yeast cells
expressing a mutant Naþ,Kþ-ATPase, in which the catalytic
site was modi¢ed to resist phosphorylation by replacement of
Asp369 with Ala, were sensitive to PTX just as the wild-type.
Their data coincide with the present ¢nding that the catalytic
domain species is not essential for the PTX-induced opening
of the channel and suggest that ATP hydrolysis by the cata-
lytic domain is not directly linked to induction of a channel by
PTX. Therefore, it seems that sustained opening of channel in
the enzyme induced by PTX is independent of phosphoryla-
tion at this site.
In contrast to Scheiner-Bobis and Schneider’s report [26]
showing that phosphorylation in the catalytic domain is not
required for channel induction by PTX, several reports
showed that ATP promoted the action of PTX [24,27,28].
Habermann’s group attributed the enhancement of the PTX
e¡ect by ATP to promotion of the PTX binding to mem-
branes [27]. In our study, sodium azide and orthovanadate
decreased the PTX-induced Kþ e¥ux in NNN- and NCN-
transfected cells. Sodium azide inhibits ATP production
through inhibition of oxidative phosphorylation in the mito-
chondria so that the inhibition of the action of PTX by so-
dium azide could be ascribed to a decrease in intracellular
Fig. 4. E¡ect of sodium orthovanadate and sodium azide on the
PTX-induced Kþ e¥ux in NNN- or NCN-transfected cells (upper
panels) and in ORNNN- or ORNCN-transfected cells (lower pan-
els). Cells were pretreated with sodium orthovanadate or sodium
azide 30 min or 2 h prior to PTX, respectively. Kþ e¥ux is ex-
pressed as percentage of total cellular K. Each point represents
meanSS.E.M. of six determinations. *P6 0.01 (vs. in the absence
of ouabain, Dunnett’s post-hoc test following ANOVA).
 
Fig. 5. Time-course of PTX-induced Kþ e¥ux from yeast cells
transfected with ORNNN or ORNCN. PTX (100 nM) was applied
at time 0 to ORNNN- (open circles) or ORNCN- (open squares)
transfected cells. Kþ e¥ux is expressed as percentage of total cellu-
lar K. Closed circles and closed squares are control Kþ e¥ux in the
absence of PTX. Each point represents meanSS.E.M. of six deter-
minations.
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ATP. Thus, ATP has a promoting e¡ect on the action of PTX
in transfected yeast cells. On the other hand, vanadate reacts
with the E2 state (extracellular Kþ accessible conformation)
of Naþ,Kþ-ATPase to form a stable intermediate that inhibits
the enzyme [29]. Inhibition of the action of PTX by vanadate
was also observed in erythrocytes [24,30] or the distal colon
[31]. Similarly to vanadate, ouabain preferentially binds to the
Naþ,Kþ-ATPase in the E2P state and inhibits the enzyme
activity [32]. Based on the data on antagonism of the PTX
action by ouabain or vanadate and acceleration of the action
by ATP, the relationship between the PTX binding and a
special state of the Naþ,Kþ-ATPase has been inferred. How-
ever, the interpretations are contradictory, e.g. some groups
argued that PTX binds to the E1 state (cytoplasmic Naþ-
accessible conformation) [23,26] while others claimed that it
binds to the E2 state [24,30]. Hence, more concrete evidence is
needed to determine what state PTX prefers for its binding.
Recently, Artigas and Gadsby [28] showed that MgATP,
MgADP and poorly hydrolyzable MgAMPPNP increased
the open probability of PTX-induced channels and suggested
that this facilitation occurred through low a⁄nity binding of
ATP (namely at the E2 state). Their data tempt us to con-
jecture another possibility that some conformational change
following binding of adenine nucleotides to the enzyme helps
PTX induce the channel, as the case that the nucleotides mod-
ulate ATP-sensitive Kþ channels with no involvement of
phosphorylation or ATP hydrolysis [33].
It was shown that PTX and ouabain compete for binding
with each other [27]. In this study, ouabain did not a¡ect the
PTX-induced Kþ e¥ux in ORNNN- or ORNCN-transfected
cells. After point mutations in the extracellular loop between
the ¢rst and second transmembrane segments ouabain cannot
bind to its high a⁄nity site but may be able to bind to low
a⁄nity sites [34]. The present data showing that PTX exerted
its e¡ect in cells where similar mutations were introduced
suggest that the binding site for PTX is not completely iden-
tical to the high a⁄nity binding site for ouabain. Since oua-
bain could not a¡ect the PTX-induced Kþ e¥ux at even 100
WM in ouabain-resistant cells, it is unlikely that the antago-
nism of the PTX action by ouabain in NNN or NCN cells is
through the binding of ouabain to the low a⁄nity site. There-
fore, the high a⁄nity binding site for ouabain could be partly
included in the binding site for PTX.
The inherent presence of a channel in the Naþ,Kþ-ATPase,
which conveys Naþ and Kþ, has been predicted for two de-
cades [7,8,35]. This channel could be uncovered when the
Naþ,Kþ-ATPase protein was incorporated in arti¢cial mem-
branes [36,37]. The similar sensitivity to ouabain, vanadate or
ATP of the channel in reconstituted systems and the PTX-
sensitive channel observed in living cells [28,30,38] suggests
that the channel observed in Naþ,Kþ-ATPase-incorporated
membranes is identical to that induced by PTX. Therefore,
it is very likely that PTX discloses a channel latent in the
Naþ,Kþ pump. A problem is why PTX alters the ion trans-
port through the enzyme from uphill movement to dissipative
movement. An important issue in connection with this prob-
lem is whether an ion occlusion mechanism is modi¢ed by
PTX. Recent work by Wu et al. [39] suggested that the N-
terminus of the K-subunit behaves as an inactivation gate of
the PTX-sensitive channel and the gate may be involved in the
E1^E2 conformational change. Therefore, it is possible that
the inactivation gate is responsible for ion occlusion. Analysis
of PTX action in cells expressing the gene-manipulated
Naþ,Kþ-ATPase will lead to clari¢cation of site and function
of a latent channel in the pump.
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